JNJ · Johnson & Johnson

255.20

USD

1.92 (0.758%)

16/10/2026 03:26:41 PM

Price change (7D)

Unlock stock Insights

Create a free account to unlock price targets, recommendations, and commentary.

Overview

Market Cap

US$630.04B

18.80

EV/EBITDA

15.8

DIV Yield

2.5%

Payout Ratio

47%

MQV Rating

4Weak

As at 16/10/2026 03:26:41 PM

Price Chart

Description

Johnson & Johnson is a holding company, which engages in the research, development, manufacture, and sale of products in the healthcare field. It operates through the Innovative Medicine and MedTech segments. The Innovative Medicine segment focuses on immunology, infectious diseases, neuroscience, oncology, cardiovascular and metabolism, and pulmonary hypertension. The MedTech segment includes a portfolio of products used in interventional solutions, orthopaedics, surgery, and vision categories. The company was founded by Robert Wood Johnson I, James Wood Johnson, and Edward Mead Johnson Sr. in 1887 and is headquartered in New Brunswick, NJ.

All-Companies
All-Consensus
HALO 200
HALO 50
HALO 500
HALO All
HALO Capital Efficiency
Hammer Bearish
Hammer Bullish

Key Fundamentals

EPS 3 yr Growth

62.90%

EBITDA Margin

35.70%

Operating Cashflow

$24,530m

Free Cash Flow Return

21.70%

ROIC

23.70%

Interest Coverage

22.60

Quick Ratio

0.80

Performance

52 weeks range

Low 184.66 - 281.07

Trade Value (12mth)

US$469,919,697.00

1 week

2.11%

1 month

-1.56%

YTD

26.09%

1 year

37.08%

All time high

281.07

Additional Data

Shares Outstanding (Fully Diluted)

2,440m

HALO Sector

Healthcare

Next Company Report Date

26-Jan-27

Next Ex Dividend Date

25-Aug-26

Next Dividend Pay Date

08-Sep-26

Reporting Currency

USD

Short Sell (% of issue)

0.00

Consensus

Unlock full consensus

Consensus score

/10

Recommendation

Buy

Target price

Deviation

Health Scores

Short Term

Mean Reversion

Neutral

Trend

Neutral

Event

Very Strong

Halo Model

Mqv

Weak

Garp

Very Weak

Mqv Small

Neutral

Momentum

Price

Neutral

Earnings

Very Weak

Growth

Earnings

Weak

Dividends

Neutral

Quality

Capital Efficiency

Very Strong

Balance Sheet

Strong

Valuation

Unlock full dataset

Value

Consensus

Yield

News & Announcements

Date	Event
13 October 26EDG
04 August 26EDG
30 July 26EDG
30 July 26EDG
28 July 26EDG

Key Stakeholders

Name	Title
Wellcome Trust Ltd. (Direct Investments)	Operating Division
Joaquin Duato	Individual
Employees Provident Fund	Pension Fund
Jennifer L. Taubert	Individual
Kathryn E. Wengel	Individual